ACTIVE

Panacea Pharma

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

63,3 k €

-44.6% YoY

Gross margin

111,9 k €

+67.8% YoY

Equity

1 M €

+6.7% YoY

What does Panacea Pharma do?

Panacea Pharma is a Private limited company incorporated in 2012. Its main activity is: Activities of holding companies. Its registered office is in Putte.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0501.960.053

Incorporation

10/12/2012

Legal form

Private limited company

Registered office

Lierbaan 37
2580 Putte · FlandreSee on map

Contributed capital

50 000,00 €

Latest accounts

30/06/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores+6

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 10 financial years

	2025		2024		2023		2022		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	111,9 k €	+67.8%	66,7 k €	-4.8%	70,1 k €	+2.5%	68,4 k €	-3.1%	70,6 k €	-9.5%	78 k €	+7.7%	72,4 k €	-0.1%	72,5 k €	-11.1%	81,5 k €	+76.1%	46,3 k €
EBITDA	110,6 k €	+69.4%	65,3 k €	-5.7%	69,2 k €	+3.2%	67 k €	-3.2%	69,2 k €	-8.8%	75,9 k €	+6.8%	71,1 k €	+0.2%	71 k €	-12.4%	81 k €	+75.4%	46,2 k €
Operating result	110,6 k €	+69.4%	65,3 k €	-5.7%	69,2 k €	+3.2%	67 k €	+9.0%	61,5 k €	-9.8%	68,2 k €	+0.8%	67,7 k €	+0.2%	67,5 k €	-12.3%	77 k €	+69.3%	45,5 k €
Net result	63,3 k €	-44.6%	114,3 k €	-0.9%	115,3 k €	-39.1%	189,4 k €	+8708%	2,2 k €	-69.4%	7 k €	+1.3%	6,9 k €	-93.0%	98,3 k €	+765%	11,4 k €	-97.1%	387,3 k €
Balance sheet
Equity	1 M €	+6.7%	945,5 k €	+7.8%	877,2 k €	+13.9%	770,5 k €	+36.8%	563,2 k €	+0.4%	561 k €	+1.3%	554 k €	+1.3%	547,1 k €	+21.9%	448,7 k €	+2.6%	437,3 k €
Total assets	1,6 M €	-0.5%	1,6 M €	+4.0%	1,5 M €	-0.6%	1,5 M €	-2.0%	1,6 M €	-1.2%	1,6 M €	+0.3%	1,6 M €	-0.4%	1,6 M €	+1.8%	1,5 M €	+0.8%	1,5 M €
Cash	29 k €	-21.3%	36,9 k €	+42.9%	25,8 k €	-27.1%	35,4 k €	+16.4%	30,4 k €	-45.3%	55,6 k €	-30.5%	80,1 k €	-4.1%	83,5 k €	+60.4%	52 k €	+10.0%	47,3 k €
Debts	556,7 k €	-11.2%	627,2 k €	-1.1%	633,9 k €	-15.5%	750,3 k €	-23.9%	986,4 k €	-0.9%	995,8 k €	-1.6%	1 M €	-1.3%	1 M €	-6.4%	1,1 M €	+0.0%	1,1 M €

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 3 ended

Active mandates

Stefan Puttemans

Director · since 10 décembre 2012

Active

Ended mandates

Stefan Puttemans

Manager · since 13 décembre 2012

Ended

Stefan Puttemans

Manager · since 10 décembre 2012

Ended

Stefan PUTTEMANS

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
APOTHEEK PUTTEMANS-VERNAILLEN● Active	0427.909.758
Vereniging van mede-eigenaars Residentie De Farmacie● Active	0749.640.150

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/11/2025	03/12/2024	04/12/2023	23/11/2022	29/11/2021	08/12/2020
General meeting	21/11/2025	15/11/2024	17/11/2023	18/11/2022	19/11/2021	20/11/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	21/11/2025	28/11/2025	Dutch	PDF
Abridged model	30/06/2024	15/11/2024	03/12/2024	Dutch	PDF
Abridged model	30/06/2023	17/11/2023	04/12/2023	Dutch	PDF
Abridged model	30/06/2022	18/11/2022	23/11/2022	Dutch	PDF
Abridged model	30/06/2021	19/11/2021	29/11/2021	Dutch	PDF
Abridged model	30/06/2020	20/11/2020	08/12/2020	Dutch	PDF
Abridged model	30/06/2019	15/11/2019	13/12/2019	Dutch	PDF
Abridged model	30/06/2018	16/11/2018	14/12/2018	Dutch	PDF
Abridged model	30/06/2017	17/11/2017	20/11/2017	Dutch	PDF
Abridged model	30/06/2016	18/11/2016	25/11/2016	Dutch	PDF
Abridged model	30/06/2015	20/11/2015	18/12/2015	Dutch	PDF
Abridged model	30/06/2014	21/11/2014	30/01/2015	Dutch	PDF
Abridged model	30/06/2013	15/11/2013	12/12/2013	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 3 ended

Active mandates

Stefan Puttemans

Director · since 10 décembre 2012

Active

Ended mandates

Stefan Puttemans

Manager · since 13 décembre 2012

Ended

Stefan Puttemans

Manager · since 10 décembre 2012

Ended

Stefan PUTTEMANS

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/11/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/08/2021
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Other24/12/2012
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202563,3 k €↓
2024
Annual accounts 2024114,3 k €↓
2023
Annual accounts 2023115,3 k €↓
2022
Annual accounts 2022189,4 k €↑
2018
Annual accounts 20182,2 k €↓
2017
Annual accounts 20177 k €↑
2016
Annual accounts 20166,9 k €↓
2015
Annual accounts 201598,3 k €↑
2014
Annual accounts 201411,4 k €↓
2013
Annual accounts 2013387,3 k €
10/12/2012
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Panacea Pharma

Overview

What does Panacea Pharma do?

Trend over 10 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline